A randomized controlled trial to change antibiotic prescribing patterns in a community

Archives of Pediatrics and Adolescent Medicine

Volumn 158, Issue 6, 2004, Pages 577-583

  Doyne, Emanuel O ^a,b   Alfaro, Mary Pat ^a   Siegel, Robert M ^a,b   Atherton, Harry D ^a   Schoettker, Pamela J ^a   Bernier, Jeralyn ^a,b   Kotagal, Uma R ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; MACROLIDE; PENICILLIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CHILD; CHILD HEALTH CARE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEALTH MAINTENANCE ORGANIZATION; HUMAN; INFECTION; PEDIATRICIAN; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COMMUNITY HEALTH SERVICES; DRUG UTILIZATION; FEMALE; HEALTH SERVICES MISUSE; HUMANS; MALE; OFFICE VISITS; OHIO; PEDIATRICS; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; PROGRAM EVALUATION; SEASONS;

EID: 2642567730     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.158.6.577     Document Type: Article

References (52)

1. Cohen ML. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science. 1992;257:1050-1055.
2. Jernigan DB, Cetron MS, Breiman RF. Minimizing the impact of drug resistant Streptococcus pneumoniae (DRSP): a strategy from the DRSP Working Group. JAMA. 1996;275:206-209.
3. Murray BE, Can antibiotic resistance be controlled [editorial]? N Engl J Med. 1994; 330:1229-1230.
4. Gorman C. Germ warfare: a drug-resistant staph strain has doctors on edge. Time. 1997;150:65.
5. Kalb C, Davenport J. A deadly strain of Staph. Newsweek, 1999;134:57.
6. Arnold KE, Leggiadro RJ, Breiman RK, et al. Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee. J Pediatr. 1996;128:757-764.
7. Holmes SJ, Solomon SL, Morrow AL, Schwartz B, Pickering LK. Risk factors for carriage of penicillin-resistant Streptococcus pneumoniae (S. pneumoniae) in young children [abstract]. Pediatr Res. 1997;41:122A.
8. Reichler MR, Allphin AA, Breiman RF, et al. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Ois. 1992;166:1346-1353.
9. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA. 1995;273:214-219.
10. Avorn J, Soumerai SB. Improving drug-therapy decisions through educational outreach: a randomized controlled trial of academically based "detailing." N Engl J Med. 1983;308:1457-1463.
11. Lomas J. Teaching Old (and Not So Old) Docs New Tricks: Effective Ways to Implement Research Findings. Hamilton, Ontario: McMaster University Centre for Health Economics and Policy Analysis; 1993. Working Paper 93-4.
12. Soumerai SB, Avorn J. Efficacy and cost-containment in hospital pharmacotherapy: state of the art and future directions. Milbank Mem Fund Q Health Soc. 1984;62:447-474.
13. Soumerai SB, Avorn J. Economic and policy analysis of university-based drug "detailing." Med Care. 1986;24:313-331.
14. Soumerai SB, Avorn J. Predictors of physician prescribing change in an educational experiment to improve medication use. Med Care. 1987;25:210-221.
15. Schaffner W, Ray WA, Federspiel CF, Miller WO. Improving antibiotic prescribing in office practice: a controlled trial of three educational methods. JAMA. 1983; 250:1728-1732.
16. Soumerai SB, Avorn J. Principles of educational outreach ("academic detailing") to improve clinical decision making. JAMA. 1990;263:549-556.
17. De Santis G, Harvey KJ, Howard D, Mashford ML, Moulds RF. Improving the quality of antibiotic prescription patterns in general practice: the role of educational intervention. Med J Aust. 1994;160:502-505.
18. Ekedahl A, Andersson SI, Hovelius B, Moistad S, Liedholm H, Melandor A. Drug prescription attitudes and behaviour of general practitioners: effects of a problem-oriented educational programme. Eur J Clin Pharmacol. 1995;47:381-387.
19. American Academy of Pediatrics, Centers for Disease Control and Prevention, American Society for Microbiology. Your Child and Antibiotics [brochure]. 1997.
20. Palmer DA, Bauchner H. Parents' and physicians' views on antibiotics. Pediatrics. 1997;99:E6.
21. Klein JO. Management of otitis media: 2000 and beyond. Pediatr Infect Dis J. 2000;19:383-387.
22. Kent H. Lack of time for communication creating "cycles of misinformation" about use of antibiotics. CMAJ. 1999;160:892.
23. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
24. Tu K, Davis D. Can we alter physician behavior by educational methods? lessons learned from studies of the management and follow-up of hypertension. J Contin Educ Health Prof. 2002;22:11-22.
25. Swartz SH, Cowan TM, DePue J, Goldstein MG. Academic profiling of tobacco-related performance measures in primary care. Nicotine Tob Res. 2002;4(suppl 1):S38-44.
26. Wilson SD, Dahl BB, Wells RD. An evidence-based clinical practice pathway for bronchiolitis safely reduces antibiotic overuse. Am J Med Qual. 2002;17:195-199.
27. Perz JF, Craig AS, Coffey CS, et al. Changes in antibiotic prescribing for children after a community-wide campaign. JAMA. 2002;287:3103-3109.
28. Finkelstein JA, Davis RL, Dowell SF, et al. Reducing antibiotic use in children: a randomized trial in 12 practices. Pediatrics. 2001;108:1-7.
29. American Society for Microbiology (ASM). Report of the ASM task force on antibiotic resistance. Antimicrob Agents Chemother. 1995;(suppl):1-23.
30. Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep. 1995; 44(RR-12):1-13.
31. Gross PA, Barrett TL, Dellinger EP, et al. Purposes of quality standards for infectious diseases: Infectious Diseases Society of America. Clin Infect Ois. 1994; 18:421.
32. Shlaes DM, Gerding DN, John JF Jr, et al. Society for Healthcare Epidemiology of American and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol. 1997;18:275-291.
33. Shye D, Brown JB. Primary care HMO clinicians' opinions about clinical practice guidelines. HMO Pract. 1995;9:111-115.
34. Tunis SR, Hayward RSA, Wilson MC, et al. Internists' attitudes about clinical practice guidelines. Ann Intern Med. 1994;120:956-963.
35. Freeborn DK, Pope CR. Promise and Performance in Managed Care: the Prepaid Group Practice Model. Baltimore, Md: Johns Hopkins University Press; 1994.
36. Kosecoff J, Kanouse DE, Rogers WH, McCloskey L, Winslow CM, Brook RH. Effects of the National Institutes of Health Consensus Development Program on physician practice. JAMA. 1987;258:2708-2713.
37. Lomas J, Anderson GM, Domnick-Pierre K, Vayda E, Enkin MW, Hannah WJ. Do practice guidelines guide practice? the effect of a consensus statement on the practice of physicians. N Engl J Med. 1989;321:1306-1311.
38. Grol R. National standard setting for quality of care in general practice: attitudes of general practitioners and response to a set of standards. Br J Gen Pract. 1990; 40:361-364.
39. Lomas J. Retailing Research: Increasing the Role of Evidence in Clinical Services for Childbirth. Hamilton, Ontario: McMaster University Centre for Health Economics and Policy Analysis; 1992. Working Paper 92-15,
40. Haynes RB, Davis DA, McKibbon A, Tugwell P. A critical appraisal of the efficacy of continuing medical education. JAMA. 1984;251:61-64.
41. Davis DA, Thomson MA, Oxman AD, Haynes RB, Evidence for the effectiveness of CME: a review of 50 randomized controlled trials. JAMA. 1992;268:1111-1117.
42. Evans CE, Haynes RB, Birkett NJ, et al. Does a mailed continuing education program improve physician performance? results of a randomized trial in antihypertensive care. JAMA. 1986;255:501-504.
43. Perlstein PH, Kotagal UR, Schoettker PJ, et al. Sustaining the implementation of an evidence-based guideline for bronchiolitis. Arch Pediatr Adolesc Med. 2000; 154:1001-1007.
44. Perlstein PH, Lichtenstein P, Cohen MB, et al. Implementing an evidence-based acute gastroenteritis guideline at a children's hospital. Jt Comm J Qual Improv. 2002;28:20-30.
45. Perlstein PH, Kotagal UR, Bolling C, et. al. Evaluation of an evidence-based guideline for bronchiolitis. Pediatrics. 1999;104:1334-1341.
46. Mittman BS, Tonesk X, Jacobson PD. Implementing clinical practice guidelines: social influence strategies and practitioner behavior change. QRB Qual Rev Bull. 1992;18:413-422.
47. Bauchner H, Pelton SI, Klein JO. Parents, physicians, and antibiotic use. Pediatrics. 1999;103:395-401.
48. Cates C. An evidence based approach to reducing antibiotic use in children with acute otitis media: controlled before and after study. BMJ. 1999;318:715-716.
49. Bauchner H, Besser RE. Promoting the appropriate use of oral antibiotics: there is some very good news. Pediatrics. 2003;111:668-670.
50. Steinman MA, Gonzales R, Linder JA, Landefeld CS. Changing use of antibiotics in community-based outpatient practice, 1991-1999. Ann Intern Med. 2003;138: 525-533.
51. Belongia EA, Sullivan BJ, Chyou PH, Madagame E, Reed KD, Schwartz B. A community intervention trial to promote judicious antibiotic use and reduce penicillin-resistant Streptococcus pneumoniae carriage in children. Pediatrics. 2001;108: 575-583.
52. Hennessy TW, Petersen KM, Bruden D, et al. Changes in antibiotic-prescribing practices and carriage of penicillin-resistant Streptococcus pneumoniae: a controlled intervention trial in rural Alaska. Clin Infect Ois. 2002;34:1543-1550.